BMS303141 is a potent inhibitor of ATP citrate lyase (ACL). BMS-303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model.
Properties:
Boiling point: 591.5±60.0 °C(Predicted)
solubility DMSO: soluble20mg/mL, clear
form: powder
pka: 4.94±0.48(Predicted)
color: white to beige
ATP-citrate lyase inhibitor Related Products:
Bempedoic acid